Indication
DFNB9
2 clinical trials
3 products
Product
OTOV101N+OTOV101CClinical trial
An Investigator Initiated Study Evaluating the Safety, Tolerability, and Efficacy of OTOV101N+OTOV101C Injection in Treating Patients With OTOF Mutation-related DeafnessStatus: Recruiting, Estimated PCD: 2024-12-06
Clinical trial
A Phase I/II, Open-ended, Adaptative, Open Label Dose Escalation and Expansion Clinical Trial to Evaluate the Efficacy and Safety of Unilateral Intracochlear Injection of SENS-501 Using an Injection System in Children With Severe to Profound Hearing Loss Due to Otoferlin Gene MutationsStatus: Not yet recruiting, Estimated PCD: 2027-04-01
Product
SENS-501Product
OTOV101